miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18230780 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.1 - Patient study phenotype-control quantitative PCR
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.3 - Patient study phenotype-control quantitative PCR
18176954 Hepatocellular carcinoma - 114550 Cancer liver miRNA overexpression - 1.42 - Patient study phenotype-phenotype miRNA microarray
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 18.8 - Cell culture study quantitative PCR
18525125 Alzheimer disease, susceptibility to - 104300 Neurological cerebrospinal fluid miRNA downregulation - 2.08 - Patient study phenotype-phenotype quantitative PCR
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA downregulation - - - Cell culture study quantitative PCR
18451220 Squamous cell carcinoma, head and neck - 601400 (Squamous cell carcinoma (SCC) of the tongue - 0) Cancer tongue miRNA overexpression - 3.15 - Patient study phenotype-control quantitative PCR
18442408 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary cancer cell miRNA overexpression - 7.7 - Patient study phenotype-phenotype quantitative PCR
18187662 Leukemia, acute myelogenous - 601626 Cancer blood miRNA downregulation - 3.23 - Patient study phenotype-control quantitative PCR
18537969 Non-Hodgkin lymphoma, somatic - 605027 Cancer lymph node miRNA overexpression - - - Patient study phenotype-control quantitative PCR
17976522 Myelofibrosis, idiopathic - 254450 Hematological granulocyte miRNA downregulation - 2.32558 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA overexpression - 2.34 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - 3.75 - Cell culture study quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 2.43902 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 2.71 - Patient study phenotype-phenotype quantitative PCR
18223217 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA overexpression - 3.0 - Patient study phenotype-phenotype quantitative PCR
18728182 Multiple myeloma - 254500 Cancer plasma cell miRNA downregulation - 6.25 - Patient study phenotype-control miRNA microarray
16754881 Ovarian cancer - 604370 Cancer ovary miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA overexpression - - - Cell culture study array CGH
18756266 Medulloblastoma - 155255 (Medulloblastoma with high Gli1 expression - 0) Cancer cerebellum miRNA downregulation - 25.0 - Patient study phenotype-control quantitative PCR
18756266 Medulloblastoma - 155255 (Medulloblastoma with low Gli1 expression - 0) Cancer cerebellum miRNA downregulation - 2.04082 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA overexpression - 2.31 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA overexpression - 2.14 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 5.21 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - 1.0101 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA downregulation - 3.57143 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA overexpression - 1.97 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 3.44828 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA overexpression - 1.17 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 1.86 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 1.0989 - Cell culture study quantitative PCR
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 5.65 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA overexpression - 2.11 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 5.81 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 1.57 - Bioprocess study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA overexpression - 2.58 - Cell culture study quantitative PCR